Brought to you by 
World Heart acquires Edwards Lifesciences' Novacor
16 Jun 2000
Executive Summary
The newly formed US subsidiary of World Heart (implantable cardiovascular devices) has acquired Edwards' (products and services to treat late-stage cardiovascular disease) ventricular assist device operation Novacor (cardiac assist device) for $58mm of its preferred shares. The shares are exchangeable into approximately 24.9% of World Heart common shares.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
World Heart acquires Edwards Lifesciences' Novacor
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice